Hi Hottod
I think the following explanation is the only thing that makes sense. I believe that Neu was in discussions with a big pharma behind closed doors and the price was dependent on the outcome of the phase 2 results. We then had over-exuberant buying after the first PMS result with a takeover in the wings. Discussions continued as the next 2 results were released and the price wasnt high enough for Neu board and so negotiations ceased. Industry insiders then sold and it has been perpetuated. Obviously this implies a leak of information which I am NOT suggesting came from NEU but likely from the other undisclosed company.
NEU chart, page-1902
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.81 |
Change
0.060(0.44%) |
Mkt cap ! $1.765B | |||
| Open | High | Low | Value | Volume |
| $13.85 | $14.08 | $13.46 | $6.963M | 507.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 3724 | $13.69 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.84 | 2087 | 1 |
View Market Depth
| Last trade - 16.10pm 10/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |